Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Queen's University (Kingston, Ontario)

$1,143,676.00

Melanoma-innervating neurons control cDC1 anti-tumor immunity.

FY 2024-25

Summary
Itching (pruritus) is common in many types of cancer, and recent research has shown that cancer cells release signals prompting nerve cells (neurons) to grow into tumors. Our previous studies indicate that blocking the electrical activity of these tumor-infiltrating neurons can slow cancer progression. However, we still do not fully understand how nerves help cancer cells survive. Our team has now discovered that tumor cells can dramatically alter the genes of the nerves that enter tumors. We suspect that cancer cells harness a particular type of nerve cell-nociceptors-to reshape the immune system in ways that favor tumor growth. Our ultimate goal is to target these tumor-invading neurons in order to boost the immune system's ability to fight cancer. Specifically, we will: 1. Determine how nociceptor neurons influence the response of certain immune cells (cDC1) to melanoma (a form of skin cancer). 2. Investigate how these cDC1 cells, in turn, affect the activity of tumor-invading neurons. By examining the interplay between the nervous system and the immune system within tumors, our research could reveal new insights into cancer biology and open up novel treatment strategies. This proposal is the first to enhance the immune system's cancer-fighting power by leveraging the partnership between nerves and immune cells.
Program
Project Grant
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
523430
Name
Talbot Sébastien
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology
Projecttitle
Melanoma-innervating neurons control cDC1 anti-tumor immunity.
Programtype2
Operating Grants
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$1,143,676
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cancer Neurosocience; Cgrp; Dendritic Cells; Immunotherapy; Melanoma; Neuro-Immunity; Nociceptor Neurons; Pain; Ramp1; Tumor Immunity
Abstract
Itching (pruritus) is common in many types of cancer, and recent research has shown that cancer cells release signals prompting nerve cells (neurons) to grow into tumors. Our previous studies indicate that blocking the electrical activity of these tumor-infiltrating neurons can slow cancer progression. However, we still do not fully understand how nerves help cancer cells survive. Our team has now discovered that tumor cells can dramatically alter the genes of the nerves that enter tumors. We suspect that cancer cells harness a particular type of nerve cell-nociceptors-to reshape the immune system in ways that favor tumor growth. Our ultimate goal is to target these tumor-invading neurons in order to boost the immune system's ability to fight cancer. Specifically, we will: 1. Determine how nociceptor neurons influence the response of certain immune cells (cDC1) to melanoma (a form of skin cancer). 2. Investigate how these cDC1 cells, in turn, affect the activity of tumor-invading neurons. By examining the interplay between the nervous system and the immune system within tumors, our research could reveal new insights into cancer biology and open up novel treatment strategies. This proposal is the first to enhance the immune system's cancer-fighting power by leveraging the partnership between nerves and immune cells.
Competitiondate
202503
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Talbot, Sébastien
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,143,676~ $0~
Queen's University (Kingston, Ontario) - $1,143,676 G… | Canada Spends